Maintenance of efficacy and safety with lebrikizumab up to one year of treatment in patients with moderate-to-severe atopic dermatitis with or without topical corticosteroids

被引：0
|
作者：
Guttman-Yassky, E. [1 ]
Weidinger, S. [2 ]
Silverberg, J. [3 ]
Gooderham, M. [4 ]
Thyssen, J. [5 ]
Irvine, A. [6 ]
Elmaraghy, H. [7 ]
Natalie, C. [7 ]
Hu, C. [7 ]
Pierce, E. [7 ]
Gil, E. G. [8 ]
Simpson, E. [9 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[2] Univ Hosp SchleswigHolstein, Dept Dermatol & Allergy, Kiel, Germany
[3] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA
[4] Skin Ctr Dermatol, Peterborough, ON, Canada
[5] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark
[6] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[7] Eli Lilly & Co, Indianapolis, IN USA
[8] Almirall SA, Barcelona, Spain
[9] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
94
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [1] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Diana Bernardo
    Thomas Bieber
    Tiago Torres
    [J]. American Journal of Clinical Dermatology, 2023, 24 : 753 - 764
  • [2] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [3] MAINTENANCE OF LEBRIKIZUMAB EFFICACY IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS WITH STABLE ASTHMA CONTROL
    Mehta, V.
    Worm, M.
    Chiesa, Z.
    Natalie, C.
    Dawson, Z.
    Zhong, J.
    Diemert, S.
    Boguniewicz, M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S89 - S90
  • [4] Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Weidinger, Stephan
    Simpson, Eric
    Gooderham, Melinda
    Irvine, Alan
    Spelman, Lynda
    Silverberg, Jonathan
    Elmaraghy, Hany
    DeLuca-Carter, Louise
    Piruzeli, Maria Lucia Buziqui
    Hu, Chaoran
    Yang, Fan Emily
    Pierce, Evangeline
    Bardolet, Laia
    Thaci, Diamant
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II3 - II4
  • [5] Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial (ADhere)
    Simpson, Eric L. L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Witte, Michael M. M.
    Xu, Wen
    ElMaraghy, Hany
    Natalie, Chitra R. R.
    Pierce, Evangeline
    Blauvelt, Andrew
    ADhere Investigators
    [J]. JAMA DERMATOLOGY, 2023, 159 (02) : 182 - 191
  • [6] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Smith, Brandon I.
    Engel, Priya
    Wu, Jashin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
  • [7] Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 3, Randomized, Placebo-Controlled Trial (ADhere)
    Simpson, Eric L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Xu, Wen
    Witte, Michael M.
    Blauvelt, Andrew
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 61 - 61
  • [8] Efficacy and safety of lebrikizumab in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis: a phase III randomized, placebo-controlled trial (ADhere)
    Simpson, Eric L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Xu, Wen
    Witte, Michael M.
    Blauvelt, Andrew
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E108 - E108
  • [9] Lebrikizumab Combined with Topical Corticosteroids Improves Patient- reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis
    Tanaka, Akio
    Igawa, Ken
    Takahashi, Hidetoshi
    Shimizu, Ryosuke
    Kataoka, Yoko
    Torisu-Itakura, Hitoe
    Morisaki, Yoji
    Montmayeur, Sonia
    Katoh, Norito
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [10] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
    Paller, Amy
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Irvine, Alan D.
    Pinto-Correia, Ana
    Natalie, Chitra R.
    Pierce, Evangeline
    Reifeis, Sarah
    Lima, Renata Gontijo
    Laquer, Vivian
    Weidinger, Stephan
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 60 - 61
12345